跳至主要内容
临床试验/NCT00782873
NCT00782873已完成不适用

Balanced Propofol Sedation During Upper Endoscopy in Morbidly Obese Patients: Assessment of Cardiopulmonary Parameters

Research Associates of New York, LLP1 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2008年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65
试验地点
1
主要终点
A change in mean arterial pressure (MAP) of 20% or more from baseline

研究概览

简要总结

The purpose of this study is to evaluate the safety of propofol-based, gastroenterologist-administered sedation in severely obese patients (BMI≥35) undergoing upper endoscopy.

The investigators aim to test the hypothesis that it is safe to use balanced-propofol, gastroenterologist-administered sedation in obese patients.

详细描述

The purpose of this study is to evaluate the safety of propofol-based, gastroenterologist-administered sedation in severely obese patients (BMI≥35) undergoing upper endoscopy. We will use changes in pulmonary and hemodynamic parameters as the primary safety measure in this study. We will compare these results in 30 non-obese patients and in 30 obese patients.

The term balanced propofol sedation refers to using a low dose of propofol in combination with small amounts of an opioid and midazolam.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing an endoscopic esophagostroduodenoscopy (EGD)
  • Capable of providing written informed consent and willing and able to comply with all procedures of the study
  • Adults between the ages of 18 and 85 inclusive (and of legal age to consent)
  • ASA score of I, II, or III

排除标准

  • Severe acute illness that is not resolved or stabilized prior to enrollment. Study entry will be based on the investigator's judgment
  • Need for sleep or narcotic analgesic medication on a continuous basis during the proceeding 6 months
  • Pregnancy
  • A history of drug addiction or alcohol abuse within the past 12 months. Alcohol can be consumed in moderation. The consumption of alcohol should be within the routine pattern for the individual before the study.
  • A history of seizure disorder.
  • Allergy to propofol, soy beans, or eggs.
  • Prior history of difficult intubation.
  • Prior history of severe complications during conscious sedation. Study entry will be based on the investigator's judgment.

结局指标

主要结局

A change in mean arterial pressure (MAP) of 20% or more from baseline

时间窗: during upper endoscopy

次要结局

  • Episodes of bradycardia - pulse less than 50(during upper endoscopy)
  • ECG changes consistent with myocardial ischemia(during upper endoscopy)
  • Decrease in respiratory rate - change of 20% or more from baseline(during upper endoscopy)
  • Assess the dose of propofol, midazolam, and fentanyl necessary to achieve adequate sedation during upper endoscopy and compare the dose requirements of the obese and non-obese patient cohorts.(after all patients completed)
  • Compare the level of sedation between the obese and non-obese cohorts(after all patients completed)
  • compare patient satisfaction with endoscopic sedation in obese and non-obese cohorts(after all patients completed)
  • Compare time to sedation in the obese and non-obese cohorts(after all patients completed)
  • Oxygen desaturation(during upper endoscopy)
  • Apneic episodes(during upper endoscopy)

研究者

发起方
Research Associates of New York, LLP
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Balanced Propofol Sedation During Upper Endoscopy in... | 临床试验